Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
cytotoxic agent |
| gptkbp:CASNumber |
gptkb:139504-50-0
|
| gptkbp:chemicalFormula |
C42H69ClN6O12S
|
| gptkbp:component |
gptkb:trastuzumab_emtansine
mirvetuximab soravtansine |
| gptkbp:derivedFrom |
gptkb:maytansine
|
| https://www.w3.org/2000/01/rdf-schema#label |
mertansine
|
| gptkbp:mechanismOfAction |
microtubule inhibitor
|
| gptkbp:molecularWeight |
925.55 g/mol
|
| gptkbp:UNII |
6T3D8C1D8W
|
| gptkbp:used_in |
antibody-drug conjugates
|
| gptkbp:usedFor |
antineoplastic agent
|
| gptkbp:bfsParent |
gptkb:DM1_(emtansine)
|
| gptkbp:bfsLayer |
7
|